Defining the optimal duration of DAPT after PCI with DES

被引：13

作者：

Eisen, Alon ^{[1
,2
]}

Bhatt, Deepak L. ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

NATURE REVIEWS CARDIOLOGY | 2015年 / 12卷 / 08期

关键词：

DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; DRUG-ELUTING STENTS;

D O I：

10.1038/nrcardio.2015.87

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Dual antiplatelet therapy is the cornerstone of treatment after druge-luting stent implantation. Although treatment for 12months is the standard of care in many parts of the world, the optimal duration of treatment is still being determined. Meta-analysis data now suggest that shorter or longer durations might yield preferred outcomes in different patient subgroups.

引用

页码：445 / 446

页数：2

共 50 条

[31] Optimal duration of dual antiplatelet therapy (DAPT) after second generation drug-eluting stent (DES) implantation in elderly patients: the SECURITY-ELDERLY substudy
Ferri, Luca Angelo
Chieffo, Alaide
Giustino, Gennaro
Frasheri, Arian
Garbo, Roberto
Masotti-Centol, Monica
Salvatella, Neus
Dominguez, Juan Francisco Oteo
Steffanon, Luigi
Tarantini, Giuseppe
Presbitero, Patrizia
Menozzi, Alberto
Pucci, Edoardo
Mauri, Josepa
Sardella, Gennaro
Colombo, Antonio
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B83 - B83
[32] Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
Toyota, Toshiaki
Shiomi, Hiroki
Morimoto, Takeshi
Natsuaki, Masahiro
Kimura, Takeshi
[J]. PLOS ONE, 2017, 12 (09):
[33] Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: a comparison between the DAPT trial and 9 other trials evaluating DAPT duration
Toyota, T.
Shiomi, H.
Morimoto, T.
Natsuaki, M.
Kimura, T.
[J]. EUROPEAN HEART JOURNAL, 2015, 36 : 234 - 234
[34] Defining PCI complexity in the contemporary DES era: Clarity or confusion?
Baber, Usman
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 94 - 95
[35] REPLY: DAPT Cessation and MACE in Elderly Patients What Is the Optimal Regimen and Duration?
Joyce, Lauren
Baber, Usman
Mehran, Roxana
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (16) : 1627 - 1628
[36] DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI
Chichareon, Ply
Modolo, Rodrigo
Kawashima, Hideyuki
Takahashi, Kuniaki
Kogame, Norihiro
Chang, Chun-Chin
Tomaniak, Mariusz
Ono, Masafumi
Walsh, Simon
Suryapranata, Harry
Cotton, James
Koning, Rene
Akin, Ibrahim
Kukreja, Neville
Wykrzykowska, Joanna
Piek, Jan J.
Garg, Scot
Hamm, Christian
Steg, Philippe Gabriel
Juni, Peter
Vranckx, Pascal
Valgimigli, Marco
Windecker, Stephan
Onuma, Yoshinobu
Serruys, Patrick W.
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (05) : 634 - 646
[37] DAPT guided by platelet function tests or genotyping after PCI: pros and cons
Angiolillo, Dominick J.
Galli, Mattia
Landi, Antonio
Valgimigli, Marco
[J]. EUROINTERVENTION, 2023, 19 (07) : 546 - 548
[38] After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo
Gallus, Alexander
[J]. ANNALS OF INTERNAL MEDICINE, 2019, 171 (10) : JC53 - JC53
[39] The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration
Luescher, Thomas F.
[J]. EUROPEAN HEART JOURNAL, 2016, 37 (04) : 319 - 321
[40] DAPT use and DES type
Bryony M. Mearns
[J]. Nature Reviews Cardiology, 2014, 11 (5) : 248 - 248

← 1 2 3 4 5 →